Cannabis
Cronos Group Appoints James Holm as Chief Financial Officer
Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced the appointment of James Holm as Chief Financial Officer, effective immediately. Mr. Holm succeeds Bob Madore, who is leaving the Company.
Mr. Holm brings to Cronos nearly two decades of finance and accounting experience at leading companies across industries. He most recently served as the Global Vice President of Finance Transformation at Vertiv, a global provider of critical digital infrastructure and continuity solutions, where he led the company’s centralization, standardization and optimization to a Global Shared Service hub for finance processes. Before joining Vertiv, Mr. Holm served as Finance Leader, Finance Solutions & Process Transformation Organization at Worldpay, one of the largest global payment processors. There he drove financial reporting accuracy, capabilities and enhancements across the company. Earlier in his career, he held multiple positions of increasing seniority in the finance department during his eight-year tenure at Procter and Gamble.
“James is a highly accomplished financial executive with diverse experience serving a variety of high growth companies across the technology, finance and consumer packaged goods industries,” said Mike Gorenstein, Chief Executive Officer of Cronos. “Not only does he bring deep financial acumen, but also, he is a strategic thinker with a proven track record of executing transformations and delivering results. We are pleased to welcome James to Cronos and are confident that he will contribute significantly to our strategic realignment plans and growth initiatives.”
Mr. Holm commented, “I am thrilled to join the Cronos team at this exciting time in its history. I look forward to working with Mike and the rest of the leadership team to further the Company’s margin expansion and revenue growth strategies while delivering enhanced value for the Company’s shareholders.”
-
Cannabis1 week ago
Mikra Announces Partnership with Virun NutraBiosciences Inc. and Releases CELLF 2.0
-
Cannabis2 weeks ago
IM Cannabis Reports First Quarter Financial Results
-
Innocan1 week ago
Innocan Pharma Reports Breakthrough in a Pre-Clinical Trial: Liposomal-CBD Injection Restores Mobility to an Amputee Female Donkey
-
Cannabis6 days ago
Global Legal Marijuana Strategic Business Report 2024: A $125+ Billion Market by 2030 Featuring Aphria, Aurora Cannabis, Beacon Medical, Canopy Growth, Cronos, OrganiGram, Tikun Olam, Tilray, Wayland
-
Cannabis6 days ago
Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa
-
Cannabis5 days ago
North America Legal Cannabis Industry Report 2024: Market to Grow at a CAGR of 26.65% During 2023-2032, Bank Loans Boosting Business Growth
-
Cannabis3 days ago
Polyethylene Films Packaging Market Size to Worth USD 139.98 Bn by 2032
-
SCHWAZZE3 days ago
Schwazze Announces First Quarter 2024 Financial Results